Combination of vinblastine and bleomycin as first line therapy in advanced classic Kaposi's sarcoma

Journal of the European Academy of Dermatology and Venereology

Volumn 20, Issue 9, 2006, Pages 1090-1094

  Brambilla, Lucia ^a   Miedico, A ^b   Ferrucci, S ^a   Romanelli, A ^b   Brambati, M ^a   Vinci, M ^b   Tedeschi, L ^b   Boneschi, V ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b SAN CARLO BORROMEO HOSPITAL   (Italy)

Author keywords

Bleomycin; Chemotherapy; Kaposi's sarcoma; Vinblastine

Indexed keywords

BLEOMYCIN; GRANULOCYTE COLONY STIMULATING FACTOR; VINBLASTINE;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE TIME EFFECT RELATION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HUMAN; KAPOSI SARCOMA; LUNG TOXICITY; MALE; NAUSEA AND VOMITING; NEUROTOXICITY; NEUTROPENIA; PATIENT COMPLIANCE; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; SARCOMA, KAPOSI; VINBLASTINE;

EID: 33748888637     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2006.01730.x     Document Type: Article

References (22)

1. Kaposi M. Idiopathisches multiples Pigmentsarkom der Haut. Arch Dermatol Syphilis 1872; 4: 265-273.
2. Chang Y, Cesarman E, Pessin M et al. Identification of new human herpesvirus-like DNA sequences in AID S-associated Kaposi's sarcoma. Science 1994; 266: 1865-1869.
3. Tappero JW, Conant MA, Wolfe SF, Berger TC. Kaposi's sarcoma: epidemiology, pathogenesis, histology, clinical spectrum, staging criteria and therapy. J Am Acad Dermatol 1993; 28: 371-395.
4. Koelle DM, Huang ML, Chandran B et al. Frequent detection of Kaposi's sarcoma-associated herpesvirus (Human herpesvirus 8) DNA in saliva of human immunodeficiency virus-infected men: Clinical and immunologic correlates. J Infect Dis 1997; 176: 94-102.
5. Brambilla L, Boneschi V, Ferrucci S, Taglioni M, Berti E. Human herpesvirus-8 infection among heterosexual partners of patients with classical Kaposi's sarcoma. Br J Dermatol 2000; 143: 1-6.
6. Antman K, Chang Y. Kaposi's sarcoma. New Engl J Med 2000; 342: 1027-1038.
7. Boneschi V, Brambilla L, Berti E et al. Human herpesvirus-8 DNA in the skin and blood of patients with Mediterranean Kaposi's sarcoma: Clinical correlations. Dermatology 2001; 203: 19-23.
8. Sanders CJG, Canniga-van Dijk M, Borleffs JC. Kaposi's sarcoma. Lancet 2004; 364: 1549-1552.
9. Brambilla L, Boneschi V, Taglioni M, Ferrucci S. Staging of classic Kaposi's sarcoma: A useful tool for therapeutic choices. Eur J Dermatol 2003; 13: 83-86.
10. Hamilton CR, Cummings BJ, Harwood AR. Radiotherapy of Kaposi's sarcoma. J Radiat Oncol Biol Phy 1986; 12: 1931-1935.
11. Odom RB, Goette DK. Treatment of cutaneous Kaposi's sarcoma with intralesional vincristine. Arch Dermatol 1978; 114: 1693-1694.
12. Klein E, Schwartz RA, Laor Y et al. Treatment of Kaposi's sarcoma with vinblastine. Cancer 1980; 45: 427-431.
13. Brambilla L, Labianca R, Fossati S et al. Vinorelbine, an active drug in Mediterranean Kaposi's sarcoma. Eur J Dermatol 1995; 5: 467-469.
14. Northfelt DW, Dezube BJ, Thommes JA et al. Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma: Results of a randomized phase III clinical trial. J Clin Oncol 1998; 16: 2445-2451.
15. Osoba D, Northfelt DW, Budd D, Himmelberger D. Effect of treatment on health-related quality of life in acquired immunodeficiency syndrome (AIDS)-related Kaposi's sarcoma: A randomized trial of pegylated-liposomal doxorubicin versus doxorubicin, bleomycin and vincristine. Cancer Invest 2001; 19: 573-580.
16. Brambilla L, Labianca R, Ferrucci S, Taglioni M, Boneschi V. Treatment of classical Kaposi's sarcoma with gemcitabine. Dermatology 2001; 202: 119-122.
17. Brambilla L, Boneschi V, Fossati S, Melotti E, Clerici M. Oral etoposide for Kaposi's Mediterranean sarcoma. Dermatology 1998; 177: 365-369.
18. Stebbing J, Wildfire A, Portsmouth SF et al. Paclitaxel for anthracycline-resistant AIDS-related Kaposi's sarcoma: Clinical and angiogenic correlation. Ann Oncol 2003; 14: 1660-1666.
19. Brambilla L, Boneschi V, De Blasio A et al. Systemic chemotherapy of Mediterranean Kaposi's sarcoma: 9 years of experience. Ann It Derm Clin Sper 1990; 44: 161-168.
20. Brambilla L, Labianca R, Boneschi V et al. Mediterranean Kaposi's sarcoma in the elderly: A randomized study of oral etoposide versus vinblastine. Cancer 1994; 74: 2873-2878.
21. Sharpe M, Easthope SE, Keating GM, Lamb HM. Polyethylene glycol-liposomal doxorubicin. A review of its use in the management of solid and haematological malignancies and AIDS-related Kaposi's sarcoma. Drugs 2002; 62: 2089-2126.
22. Jules-Elyaee K, White DA. Bleomycin-induced pulmonary toxicity. Clin Chest Med 1990; 11: 1-20.